Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 119

1.

A consideration for efficient unrelated hematopoietic stem cell source acquisition-from an experience of Japan.

Nishiwaki S, Miyamura K, Kanda Y, Takanashi M, Uchida N, Fukuda T, Ikegame K, Ohashi K, Eto T, Ozawa Y, Shiratori S, Iwato K, Matsuoka KI, Hidaka M, Ichinohe T, Atsuta Y, Kodera Y, Okamoto S.

Bone Marrow Transplant. 2019 May 14. doi: 10.1038/s41409-019-0542-0. [Epub ahead of print] No abstract available.

PMID:
31089273
2.

Risk stratification and prognosticators of acute myeloid leukemia with myelodysplasia-related changes patients undergoing allogeneic stem cell transplantation: a retrospective study of the Adult Acute Myeloid Leukemia Working Group of the Japan Society for Hematopoietic Cell Transplantation.

Harada K, Konuma T, Machida S, Mori J, Aoki J, Uchida N, Ohashi K, Fukuda T, Tanaka M, Ikegame K, Ozawa Y, Iwato K, Eto T, Onizuka M, Ichinohe T, Atsuta Y, Yano S.

Biol Blood Marrow Transplant. 2019 May 2. pii: S1083-8791(19)30272-1. doi: 10.1016/j.bbmt.2019.04.025. [Epub ahead of print]

PMID:
31054982
3.

Better disease control before allogeneic stem cell transplantation is crucial to improve the outcomes of transplantation for acute myeloid leukemia patients with extramedullary disease.

Yamasaki S, Aoki J, Mori J, Mizuno S, Uchida N, Ohashi K, Fukuda T, Ikegame K, Eto T, Ogawa Y, Tanaka M, Hidaka M, Iwato K, Sawa M, Ichinohe T, Kanda Y, Atsuta Y, Yanada M, Yano S; Adult Acute Myeloid Leukemia Working Group of the Japan Society for Hematopoietic Cell Transplantation.

Bone Marrow Transplant. 2019 Apr 10. doi: 10.1038/s41409-019-0527-z. [Epub ahead of print] No abstract available.

PMID:
30971777
4.

Low incidence of HHV-6 reactivation in haploidentical hematopoietic stem cell transplantation with corticosteroid as graft-vs-host disease prophylaxis compared with cord blood transplantation.

Tamaki H, Ikegame K, Yoshihara S, Kaida K, Yoshihara K, Inoue T, Kato R, Nakata J, Fujioka T, Soma T, Okada M, Ogawa H.

Transpl Infect Dis. 2019 Mar 15:e13073. doi: 10.1111/tid.13073. [Epub ahead of print]

PMID:
30875143
5.

Lateral thoracoaxillar dermal-fat flap for breast conserving surgery: the changes of the indication and long-term results.

Nakagomi H, Inoue M, Nakada H, Ohmori M, Nakayama Y, Furuya K, Watanabe H, Ikegame K, Kobayashi K.

Breast Cancer. 2019 Mar 7. doi: 10.1007/s12282-019-00959-2. [Epub ahead of print]

PMID:
30847663
6.

Comparison of Outcomes of Allogeneic Transplantation for Primary Myelofibrosis among Hematopoietic Stem Cell Source Groups.

Murata M, Takenaka K, Uchida N, Ozawa Y, Ohashi K, Kim SW, Ikegame K, Kanda Y, Kobayashi H, Ishikawa J, Ago H, Hirokawa M, Fukuda T, Atsuta Y, Kondo T.

Biol Blood Marrow Transplant. 2019 Mar 1. pii: S1083-8791(19)30144-2. doi: 10.1016/j.bbmt.2019.02.019. [Epub ahead of print]

PMID:
30826464
7.

Effect of low platelet HLA-C expression on donor-specific antibody depletion following platelet transfusion from a corresponding HLA donor.

Yamashita T, Ikegame K, Ito F, Kobayashi T, Nara M, Fujishima N, Anbai A, Inoue T, Kaida K, Tanaka H, Takahashi N.

Bone Marrow Transplant. 2019 Mar 1. doi: 10.1038/s41409-019-0482-8. [Epub ahead of print] No abstract available.

PMID:
30824816
8.

Risk Factors and Predictive Scoring System For Post-Transplant Lymphoproliferative Disorder after Hematopoietic Stem Cell Transplantation.

Fujimoto A, Hiramoto N, Yamasaki S, Inamoto Y, Uchida N, Maeda T, Mori T, Kanda Y, Kondo T, Shiratori S, Miyakoshi S, Ishiyama K, Ikegame K, Matsuhashi Y, Tanaka J, Ichinohe T, Atsuta Y, Ogata M, Suzuki R.

Biol Blood Marrow Transplant. 2019 Feb 20. pii: S1083-8791(19)30141-7. doi: 10.1016/j.bbmt.2019.02.016. [Epub ahead of print]

PMID:
30794929
9.

Hematopoietic stem-cell transplantation in children with refractory acute myeloid leukemia.

Okamoto Y, Kudo K, Tabuchi K, Tomizawa D, Taga T, Goto H, Yabe H, Nakazawa Y, Koh K, Ikegame K, Yoshida N, Uchida N, Watanabe K, Koga Y, Inoue M, Kato K, Atsuta Y, Ishida H.

Bone Marrow Transplant. 2019 Feb 4. doi: 10.1038/s41409-019-0461-0. [Epub ahead of print]

PMID:
30718800
10.

HLA discrepancy between graft and host rather than that graft and first donor impact the second transplant outcome.

Maeda Y, Ugai T, Kondo E, Ikegame K, Murata M, Uchida N, Miyamoto T, Takahashi S, Ohashi K, Nakamae H, Fukuda T, Onizuka M, Eto T, Ota S, Hirokawa M, Ichinohe T, Atsuta Y, Kanda Y, Kanda J; HLA Working Group of the Japan Society for Hematopoietic Cell Transplantation.

Haematologica. 2019 May;104(5):1055-1061. doi: 10.3324/haematol.2018.204438. Epub 2018 Dec 6.

11.

Fatigue, Muscle Oxygen Consumption and Blood Flow to the Skeletal Muscle After Allogeneic Hematopoietic Stem Cell Transplantation.

Morishita S, Wakasugi T, Kaida K, Itani Y, Ikegame K, Ogawa H, Domen K.

Adv Exp Med Biol. 2018;1072:293-298. doi: 10.1007/978-3-319-91287-5_47.

PMID:
30178361
12.

Hemoglobin Dynamics in the Skeletal Muscle of Patients with Malignant Hematopoietic Disease.

Wakasugi T, Morishita S, Kaida K, Itani Y, Kodama N, Ikegame K, Ogawa H, Domen K.

Adv Exp Med Biol. 2018;1072:287-291. doi: 10.1007/978-3-319-91287-5_46.

PMID:
30178360
13.

Fat necrosis after breast-conserving oncoplastic surgery.

Nakada H, Inoue M, Furuya K, Watanabe H, Ikegame K, Nakayama Y, Ohmori M, Nakagomi H.

Breast Cancer. 2019 Jan;26(1):125-130. doi: 10.1007/s12282-018-0901-5. Epub 2018 Aug 27.

PMID:
30151780
14.

Changes in Borg scale for resistance training and test of exercise tolerance in patients undergoing allogeneic hematopoietic stem cell transplantation.

Morishita S, Wakasugi T, Tanaka T, Harada T, Kaida K, Ikegame K, Ogawa H, Domen K.

Support Care Cancer. 2018 Sep;26(9):3217-3223. doi: 10.1007/s00520-018-4168-3. Epub 2018 Apr 6.

PMID:
29626261
15.

Impaired skeletal muscle oxygenation following allogeneic hematopoietic stem cell transplantation is associated with exercise capacity.

Wakasugi T, Morishita S, Kaida K, Itani Y, Kodama N, Ikegame K, Ogawa H, Domen K.

Support Care Cancer. 2018 Jul;26(7):2149-2160. doi: 10.1007/s00520-017-4036-6. Epub 2018 Jan 25.

PMID:
29372395
16.

Impact of pretransplant leukemic blast% in bone marrow and peripheral blood on transplantation outcomes of patients with acute myeloid leukemia undergoing allogeneic stem cell transplantation in non-CR.

Ogawa H, Ikegame K, Daimon T, Uchida N, Fukuda T, Kakihana K, Eto T, Ozawa Y, Kanamori H, Hidaka M, Iwato Y, Ichinohe T, Takanashi M, Atsuta Y, Kanda Y.

Bone Marrow Transplant. 2018 Apr;53(4):478-482. doi: 10.1038/s41409-017-0028-x. Epub 2018 Jan 12. No abstract available.

PMID:
29330394
17.

A prospective multicenter phase II study of intrabone marrow transplantation of unwashed cord blood using reduced-intensity conditioning.

Okada M, Tasaka T, Ikegame K, Aotsuka N, Kobayashi T, Najima Y, Matsuhashi Y, Wada H, Tokunaga H, Masuda S, Utsu Y, Yoshihara S, Kaida K, Daimon T, Ogawa H.

Eur J Haematol. 2018 Apr;100(4):335-343. doi: 10.1111/ejh.12999. Epub 2018 Jan 17.

PMID:
29168236
18.

Impact of the presence of HLA 1-locus mismatch and the use of low-dose antithymocyte globulin in unrelated bone marrow transplantation.

Kawamura K, Kanda J, Fuji S, Murata M, Ikegame K, Yoshioka K, Fukuda T, Ozawa Y, Uchida N, Iwato K, Sakura T, Hidaka M, Hashimoto H, Ichinohe T, Atsuta Y, Kanda Y.

Bone Marrow Transplant. 2017 Oct;52(10):1390-1398. doi: 10.1038/bmt.2017.153. Epub 2017 Jul 17.

PMID:
28714944
19.

Relationship of physical activity with physical function and health-related quality of life in patients having undergone allogeneic haematopoietic stem-cell transplantation.

Morishita S, Kaida K, Yamauchi S, Wakasugi T, Ikegame K, Ogawa H, Domen K.

Eur J Cancer Care (Engl). 2017 Jul;26(4). doi: 10.1111/ecc.12669. Epub 2017 Feb 21.

PMID:
28220548
20.

Effective desensitization of donor-specific HLA antibodies using platelet transfusion bearing targeted HLA in a case of HLA-mismatched allogeneic stem cell transplantation.

Yamashita T, Ikegame K, Kojima H, Tanaka H, Kaida K, Inoue T, Ogawa H.

Bone Marrow Transplant. 2017 May;52(5):794-796. doi: 10.1038/bmt.2017.10. Epub 2017 Feb 6. No abstract available.

PMID:
28165448
21.

Specific sites of metastases in invasive lobular carcinoma: a retrospective cohort study of metastatic breast cancer.

Inoue M, Nakagomi H, Nakada H, Furuya K, Ikegame K, Watanabe H, Omata M, Oyama T.

Breast Cancer. 2017 Sep;24(5):667-672. doi: 10.1007/s12282-017-0753-4. Epub 2017 Jan 20.

PMID:
28108967
22.

Spousal hematopoietic stem cell transplantation.

Ikegame K, Kaida K, Yoshihara S, Yoshihara K, Ishii S, Inoue T, Okada M, Tamaki H, Soma T, Kusunoki Y, Kojima H, Saji H, Ogawa H.

Int J Hematol. 2017 May;105(5):646-657. doi: 10.1007/s12185-016-2168-y. Epub 2016 Dec 24.

PMID:
28013483
23.

Low-dose thymoglobulin as second-line treatment for steroid-resistant acute GvHD: an analysis of the JSHCT.

Murata M, Ikegame K, Morishita Y, Ogawa H, Kaida K, Nakamae H, Ikeda T, Nishida T, Inoue M, Eto T, Kubo K, Sakura T, Mori T, Uchida N, Ashida T, Matsuhashi Y, Miyazaki Y, Ichinohe T, Atsuta Y, Teshima T.

Bone Marrow Transplant. 2017 Feb;52(2):252-257. doi: 10.1038/bmt.2016.247. Epub 2016 Nov 21.

PMID:
27869808
24.

Report of a case with gallbladder carcinoma: P53 expression of the peritumor epithelium might predict biliary tract recurrence.

Takano A, Nakagomi H, Ikegame K, Yamamoto A, Watanabe H, Nakada H, Inoue M, Sugai H, Yasutome M, Furuya K, Hada M, Miyasaka Y, Oyama T, Omata M.

Int J Surg Case Rep. 2016;28:325-329. doi: 10.1016/j.ijscr.2016.10.042. Epub 2016 Oct 18.

25.

Comparison of graft-versus-host disease-free, relapse-free survival according to a variety of graft sources: antithymocyte globulin and single cord blood provide favorable outcomes in some subgroups.

Inamoto Y, Kimura F, Kanda J, Sugita J, Ikegame K, Nakasone H, Nannya Y, Uchida N, Fukuda T, Yoshioka K, Ozawa Y, Kawano I, Atsuta Y, Kato K, Ichinohe T, Inoue M, Teshima T; JSHCT GVHD Working Group.

Haematologica. 2016 Dec;101(12):1592-1602. Epub 2016 Aug 4.

26.

Haploidentical and Matched Sibling Donor Hematopoietic Cell Transplantation for Patients with HLA-Homozygous Haplotypes.

Kanda J, Ikegame K, Fuji S, Kurokawa M, Kanamori H, Fukuda T, Ohashi K, Ishikawa J, Ogawa H, Inoue M, Ichinohe T, Atsuta Y, Kanda Y; HLA Working Group of the Japan Society for Hematopoietic Cell Transplantation.

Biol Blood Marrow Transplant. 2016 Nov;22(11):2031-2037. doi: 10.1016/j.bbmt.2016.07.020. Epub 2016 Aug 1.

27.

Allogeneic stem cell transplantation for X-linked agammaglobulinemia using reduced intensity conditioning as a model of the reconstitution of humoral immunity.

Ikegame K, Imai K, Yamashita M, Hoshino A, Kanegane H, Morio T, Kaida K, Inoue T, Soma T, Tamaki H, Okada M, Ogawa H.

J Hematol Oncol. 2016 Feb 13;9:9. doi: 10.1186/s13045-016-0240-y.

28.

Host Foxp3+CD4+ Regulatory T Cells Act as a Negative Regulator of Dendritic Cells in the Peritransplantation Period.

Inoue T, Ikegame K, Kaida K, Okada M, Yoshihara S, Tamaki H, Fujimori Y, Soma T, Ogawa H.

J Immunol. 2016 Jan 1;196(1):469-83. doi: 10.4049/jimmunol.1402950. Epub 2015 Nov 30.

29.

Balance function in patients who had undergone allogeneic hematopoietic stem cell transplantation.

Morishita S, Kaida K, Aoki O, Yamauchi S, Wakasugi T, Ikegame K, Ogawa H, Domen K.

Gait Posture. 2015 Sep;42(3):406-8. doi: 10.1016/j.gaitpost.2015.07.011. Epub 2015 Jul 21.

PMID:
26233580
30.

Early detection of cytomegalovirus-specific cytotoxic T lymphocytes against cytomegalovirus antigenemia in human leukocyte antigen haploidentical hematopoietic stem cell transplantation.

Kato R, Tamaki H, Ikegame K, Yoshihara S, Kaida K, Taniguchi K, Inoue T, Ishii S, Nakata J, Fujioka T, Eguchi R, Soma T, Okada M, Ogawa H.

Ann Hematol. 2015 Oct;94(10):1707-15. doi: 10.1007/s00277-015-2446-4. Epub 2015 Jul 22.

PMID:
26193851
31.

Pharmacokinetics of 8 mg/kg anti-human T-lymphocyte rabbit immunoglobulin conditioning for hematopoietic stem cell transplantation in Japanese patients.

Kaida K, Ikegame K, Suzuki H, Shibayama Y, Ogawa H.

Rinsho Ketsueki. 2015 May;56(5):475-80. doi: 10.11406/rinketsu.56.475. Japanese.

PMID:
26062668
32.

Unmanipulated Haploidentical Reduced-Intensity Stem Cell Transplantation Using Fludarabine, Busulfan, Low-Dose Antithymocyte Globulin, and Steroids for Patients in Non-Complete Remission or at High Risk of Relapse: A Prospective Multicenter Phase I/II Study in Japan.

Ikegame K, Yoshida T, Yoshihara S, Daimon T, Shimizu H, Maeda Y, Ueda Y, Kaida K, Ishii S, Taniguchi K, Okada M, Tamaki H, Okumura H, Kaya H, Kurokawa T, Kodera Y, Taniguchi S, Kanda Y, Ogawa H.

Biol Blood Marrow Transplant. 2015 Aug;21(8):1495-505. doi: 10.1016/j.bbmt.2015.04.012. Epub 2015 Apr 25.

33.

Early-phase differences in health-related quality of life, psychological status, and physical function between human leucocyte antigen-haploidentical and other allogeneic haematopoietic stem cell transplantation recipients.

Morishita S, Kaida K, Yamauchi S, Wakasugi T, Ikegame K, Kodama N, Ogawa H, Domen K.

Eur J Oncol Nurs. 2015 Oct;19(5):443-50. doi: 10.1016/j.ejon.2015.02.002. Epub 2015 Apr 21.

PMID:
25911269
34.

[Current and future status of haploidentical hematopoietic stem cell transplantation].

Ikegame K, Ogawa H.

Rinsho Ketsueki. 2015 Mar;56(3):289-97. doi: 10.11406/rinketsu.56.289. Review. Japanese.

PMID:
25876782
35.

A single high-resolution HLA mismatch has a similar adverse impact on the outcome of related hematopoietic stem cell transplantation as a single low-resolution HLA mismatch.

Fuji S, Kanda J, Kato S, Ikegame K, Morishima S, Miyamoto T, Hidaka M, Kubo K, Miyamura K, Tsudo M, Kobayashi H, Maesako Y, Eto T, Adachi S, Ichinohe T, Atsuta Y, Kanda Y; HLA Working Group of the Japan Society for Hematopoietic Cell Transplantation.

Am J Hematol. 2015 Jul;90(7):618-23. doi: 10.1002/ajh.24028.

36.

Risk analysis of falls in patients undergoing allogeneic hematopoietic stem cell transplantation.

Ueki S, Ikegame K, Kozawa M, Miyamoto J, Mori R, Ogawa H.

Clin J Oncol Nurs. 2014 Aug;18(4):396-9. doi: 10.1188/14.CJON.396-399.

PMID:
25095291
37.

Impact of HLA allele mismatch on the clinical outcome in serologically matched related hematopoietic SCT.

Fuji S, Kanda J, Kato S, Ikegame K, Morishima S, Miyamoto T, Hidaka M, Kubo K, Miyamura K, Ohashi K, Kobayashi H, Maesako Y, Adachi S, Ichinohe T, Atsuta Y, Kanda Y; HLA Working Group of Japan Society for Hematopoietic Cell Transplantation.

Bone Marrow Transplant. 2014 Sep;49(9):1187-92. doi: 10.1038/bmt.2014.141. Epub 2014 Jul 7.

PMID:
25000457
38.

Soluble interleukin-2 receptor level on day 7 as a predictor of graft-versus-host disease after HLA-haploidentical stem cell transplantation using reduced-intensity conditioning.

Kaida K, Ikegame K, Ikemoto J, Murata R, Irie R, Yoshihara S, Ishii S, Okada M, Inoue T, Tamaki H, Soma T, Fujimori Y, Kai S, Ogawa H.

Int J Hematol. 2014 Apr;99(4):463-70. doi: 10.1007/s12185-014-1542-x. Epub 2014 Mar 6.

PMID:
24599414
39.

Continuing increased risk of oral/esophageal cancer after allogeneic hematopoietic stem cell transplantation in adults in association with chronic graft-versus-host disease.

Atsuta Y, Suzuki R, Yamashita T, Fukuda T, Miyamura K, Taniguchi S, Iida H, Uchida T, Ikegame K, Takahashi S, Kato K, Kawa K, Nagamura-Inoue T, Morishima Y, Sakamaki H, Kodera Y; Japan Society for Hematopoietic Cell Transplantation.

Ann Oncol. 2014 Feb;25(2):435-41. doi: 10.1093/annonc/mdt558. Epub 2014 Jan 7.

PMID:
24399081
40.

Reduced-intensity allogeneic stem cell transplantation for patients aged 50 years or older with B-cell ALL in remission: a retrospective study by the Adult ALL Working Group of the Japan Society for Hematopoietic Cell Transplantation.

Kanamori H, Mizuta S, Kako S, Kato H, Nishiwaki S, Imai K, Shigematsu A, Nakamae H, Tanaka M, Ikegame K, Yujiri T, Fukuda T, Minagawa K, Eto T, Nagamura-Inoue T, Morishima Y, Suzuki R, Sakamaki H, Tanaka J.

Bone Marrow Transplant. 2013 Nov;48(12):1513-8. doi: 10.1038/bmt.2013.140. Epub 2013 Sep 23. Erratum in: Bone Marrow Transplant. 2013 Nov;48(12):1587.

PMID:
24056740
41.

Irreversible neurological defects in the lower extremities after haploidentical stem cell transplantation: possible association with nelarabine.

Kawakami M, Taniguchi K, Yoshihara S, Ishii S, Kaida K, Ikegame K, Okada M, Watanabe S, Nishina T, Hamada H, Nakagawa M, Ogawa H.

Am J Hematol. 2013 Oct;88(10):853-7. doi: 10.1002/ajh.23502. Epub 2013 Jul 23.

42.

Impact of hepatitis C virus infection on clinical outcome in recipients after allogeneic hematopoietic cell transplantation.

Nakasone H, Kurosawa S, Yakushijin K, Taniguchi S, Murata M, Ikegame K, Kobayashi T, Eto T, Miyamura K, Sakamaki H, Morishima Y, Nagamura T, Suzuki R, Fukuda T.

Am J Hematol. 2013 Jun;88(6):477-84. doi: 10.1002/ajh.23436. Epub 2013 May 13.

43.

Relationship between corticosteroid dose and declines in physical function among allogeneic hematopoietic stem cell transplantation patients.

Morishita S, Kaida K, Yamauchi S, Sota K, Ishii S, Ikegame K, Kodama N, Ogawa H, Domen K.

Support Care Cancer. 2013 Aug;21(8):2161-9. doi: 10.1007/s00520-013-1778-7. Epub 2013 Mar 9.

PMID:
23475197
44.

Impact of a donor source on adult Philadelphia chromosome-negative acute lymphoblastic leukemia: a retrospective analysis from the Adult Acute Lymphoblastic Leukemia Working Group of the Japan Society for Hematopoietic Cell Transplantation.

Nishiwaki S, Miyamura K, Ohashi K, Kurokawa M, Taniguchi S, Fukuda T, Ikegame K, Takahashi S, Mori T, Imai K, Iida H, Hidaka M, Sakamaki H, Morishima Y, Kato K, Suzuki R, Tanaka J; Adult Acute Lymphoblastic Leukemia Working Group of the Japan Society for Hematopoietic Cell Transplantation.

Ann Oncol. 2013 Jun;24(6):1594-602. doi: 10.1093/annonc/mds655. Epub 2013 Jan 31.

PMID:
23372050
45.

Detection of donor-derived CMV-specific T cells in cerebrospinal fluid in a case of CMV meningoencephalitis after cord blood stem cell transplantation.

Ikegame K, Kato R, Fujioka T, Okada M, Kaida K, Ishii S, Yoshihara S, Inoue T, Taniguchi K, Tamaki H, Soma T, Ogawa H.

Int J Hematol. 2013 Feb;97(2):287-90. doi: 10.1007/s12185-012-1231-6. Epub 2012 Dec 29.

PMID:
23271411
46.

Safety and feasibility of physical therapy in cytopenic patients during allogeneic haematopoietic stem cell transplantation.

Morishita S, Kaida K, Setogawa K, Kajihara K, Ishii S, Ikegame K, Kodama N, Ogawa H, Domen K.

Eur J Cancer Care (Engl). 2013 May;22(3):289-99. doi: 10.1111/ecc.12027. Epub 2012 Dec 18.

PMID:
23252444
47.

Frequency of CD4(+)FOXP3(+) regulatory T-cells at early stages after HLA-mismatched allogeneic hematopoietic SCT predicts the incidence of acute GVHD.

Fujioka T, Tamaki H, Ikegame K, Yoshihara S, Taniguchi K, Kaida K, Kato R, Inoue T, Nakata J, Ishii S, Soma T, Okada M, Ogawa H.

Bone Marrow Transplant. 2013 Jun;48(6):859-64. doi: 10.1038/bmt.2012.232. Epub 2012 Nov 19.

PMID:
23165499
48.

Low incidences of acute and chronic graft-versus-host disease after unrelated bone marrow transplantation with low-dose anti-T lymphocyte globulin.

Hatanaka K, Fuji S, Ikegame K, Kato R, Wake A, Hidaka M, Ito T, Inoue M, Nagatoshi Y, Takami A, Uike N, Sakamaki H, Yabe H, Morishima Y, Suzuki R, Atsuta Y, Fukuda T.

Int J Hematol. 2012 Dec;96(6):773-80. doi: 10.1007/s12185-012-1209-4. Epub 2012 Nov 7. Erratum in: Int J Hematol. 2013 Jan;97(1):154-5.

PMID:
23132596
49.

Different mechanisms causing loss of mismatched human leukocyte antigens in relapsing t(6;11)(q27;q23) acute myeloid leukemia after haploidentical transplantation.

Tamaki H, Fujioka T, Ikegame K, Yoshihara S, Kaida K, Taniguchi K, Kato R, Tokugawa T, Nakata J, Inoue T, Yano A, Eguchi R, Okada M, Maruya E, Saji H, Ogawa H.

Eur J Haematol. 2012 Dec;89(6):497-500. doi: 10.1111/ejh.12017. Epub 2012 Oct 26.

PMID:
23033942
50.

Haploidentical hematopoietic stem cell transplantation for lymphoma with monosomy of chromosome 6 (loss of heterozygosity in the HLA region)--who should be a donor?

Ikegame K, Kaida K, Lakoma L, Ishii S, Inoue T, Kato R, Soma T, Okada M, Ogawa H.

Transpl Immunol. 2012 Dec;27(4):162-5. doi: 10.1016/j.trim.2012.09.002. Epub 2012 Sep 19.

PMID:
23000337

Supplemental Content

Loading ...
Support Center